Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016:2016:2475067.
doi: 10.1155/2016/2475067. Epub 2016 May 5.

Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens

Affiliations
Review

Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens

Sirijan Santajit et al. Biomed Res Int. 2016.

Abstract

The ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) are the leading cause of nosocomial infections throughout the world. Most of them are multidrug resistant isolates, which is one of the greatest challenges in clinical practice. Multidrug resistance is amongst the top three threats to global public health and is usually caused by excessive drug usage or prescription, inappropriate use of antimicrobials, and substandard pharmaceuticals. Understanding the resistance mechanisms of these bacteria is crucial for the development of novel antimicrobial agents or other alternative tools to combat these public health challenges. Greater mechanistic understanding would also aid in the prediction of underlying or even unknown mechanisms of resistance, which could be applied to other emerging multidrug resistant pathogens. In this review, we summarize the known antimicrobial resistance mechanisms of ESKAPE pathogens.

PubMed Disclaimer

References

    1. Magill S. S., Edwards J. R., Bamberg W., et al. Multistate point-prevalence survey of health care-associated infections. The New England Journal of Medicine. 2014;370(13):1198–1208. doi: 10.1056/nejmoa1306801. - DOI - PMC - PubMed
    1. Klevens R. M., Edwards J. R., Richards C. L., Jr., et al. Estimating health care-associated infections and deaths in U.S. Hospitals, 2002. Public Health Reports. 2007;122(2):160–166. - PMC - PubMed
    1. Rice L. B. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. Journal of Infectious Diseases. 2008;197(8):1079–1081. doi: 10.1086/533452. - DOI - PubMed
    1. Bush K., Jacoby G. A. Updated functional classification of β-lactamases. Antimicrobial Agents and Chemotherapy. 2010;54(3):969–976. doi: 10.1128/aac.01009-09. - DOI - PMC - PubMed
    1. Rice L. B. Progress and challenges in implementing the research on ESKAPE pathogens. Infection Control and Hospital Epidemiology. 2010;31(supplement 1):S7–S10. doi: 10.1086/655995. - DOI - PubMed

MeSH terms

LinkOut - more resources